VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 124 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,161,557 | -36.2% | 401,666 | -1.0% | 0.00% | -50.0% |
| Q2 2023 | $9,655,529 | +2.3% | 405,865 | +9.4% | 0.00% | 0.0% |
| Q1 2023 | $9,436,356 | -10.7% | 370,926 | +2.6% | 0.00% | 0.0% |
| Q4 2022 | $10,564,936 | +88.8% | 361,689 | +32.6% | 0.00% | +100.0% |
| Q3 2022 | $5,595,000 | +98.2% | 272,811 | +11.8% | 0.00% | 0.0% |
| Q2 2022 | $2,823,000 | +170.4% | 243,956 | +331.9% | 0.00% | – |
| Q1 2022 | $1,044,000 | -11.0% | 56,487 | -4.8% | 0.00% | – |
| Q4 2021 | $1,173,000 | +105.8% | 59,328 | +71.2% | 0.00% | – |
| Q3 2021 | $570,000 | -1.0% | 34,651 | +10.1% | 0.00% | – |
| Q2 2021 | $576,000 | – | 31,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
| COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
| Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
| Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
| BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
| Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
| Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
| Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |